Cargando…
A framework to assess the impact of applying formal criteria to check clinical relevance on top of statistical significance
Autores principales: | Vach, Werner, Gladstone, Beryl Primrose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980969/ http://dx.doi.org/10.1186/1745-6215-14-S1-O101 |
Ejemplares similares
-
Is there a danger of “biocreep” with non-inferiority trials?
por: Beryl, Primrose, et al.
Publicado: (2011) -
Choice of Non-Inferiority (NI) Margins Does Not Protect against Degradation of Treatment Effects on an Average – An Observational Study of Registered and Published NI Trials
por: Gladstone, Beryl Primrose, et al.
Publicado: (2014) -
Potential role of “the compensating benefit” in claiming non-inferiority
por: Beryl, Primrose, et al.
Publicado: (2013) -
Determining clinical significance independently from statistical significance? Implications for practice
por: Schreiber, S, et al.
Publicado: (2012) -
A framework to assess the added value of subgroup analyses when the overall treatment effect (TE) was significant
por: Sun, Hong, et al.
Publicado: (2013)